Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.334EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.334EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.334ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.334ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.589EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.589EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.589ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.589ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.589EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.589EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.589ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.589ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.335EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.335EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.335ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-21266.5Germany
B.1.335ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.335EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.335EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.335ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.335ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.438.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.438.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.438.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.438.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.438.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.290EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.290EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.290ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.290ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.290EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.290EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.290ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.290ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.341EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.341EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.341ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.341ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.341EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.341EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.341ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.341ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.161EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.161EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.161ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.161ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.161EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.161EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used